Prevention of Pregnancy

• CLINICAL_TRIALS trial_result · 2023-05-03
  Clinical Trial Update: E4/DRSP Ovarian Function Inhibition Study [Phase 2]

  Phase 2 trial of E4/DRSP for prevention of pregnancy has been completed.

• FDA approval · 2019-07-03
  FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals' supplemental application for Norgestimate and Ethinyl Estradiol, a generic combined oral contraceptive.

• FDA label_change · 2018-05-29
  FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved a labeling supplement for a combined oral contraceptive containing norethindrone acetate, ethinyl estradiol, and ferrous fumara…

• FDA approval · 2017-04-28
  FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL — Original Application (Naari Pte Limited)

  FDA approves the original application for norethindrone and ethinyl estradiol as a generic oral contraceptive by Naari Pte Limited.

• FDA approval · 2014-02-21
  FDA Approved: PORTIA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for PORTIA (levonorgestrel and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc., updating …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.